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Progressive multifocal leukoencephalopathy (PML) is a fatal demyelinating disorder of the CNS caused by infection of glial cells with the
polyomavirus, JCV. Here we report that genomic stability and DNA repair are significantly dysregulated by JCV infection of human astrocytes.
Metaphase spreads exhibited increased ploidy correlating with duration of infection. Increased micronuclei formation and phospho-Histone2AX
expression also indicated DNA damage. Western blot analysis revealed perturbation in expression of some DNA repair proteins including a large
elevation of Rad51. Immunohistochemistry on clinical samples of PML showed robust labeling for Rad51 in nuclei of bizarre astrocytes and
inclusion body-bearing oligodendrocytes that are characteristic of JCV infection. Finally, in vitro end-joining DNA repair was altered in extracts
prepared from JCV-infected human astrocytes. Alterations in DNA repair pathways may be important for the life cycle of JCV and the
pathogenesis of PML.
© 2007 Elsevier Inc. All rights reserved.Keywords: JCV; DNA repair; DNA damage; PML; PolyomavirusIntroduction
The fatal demyelinating disease, progressive multifocal
leukoencephalopathy (PML), is caused by the cytolytic
destruction of oligodendrocytes in the brain as a result of the
replication of the human gliotropic polyomavirus, JC virus
(JCV). JCV is very common in the human population. However
since the virus is readily controlled by the immune system,
infection is usually subclinical and JCVenters a state of latency
which is poorly understood but is generally defined as the
presence of viral genome in the absence of viral gene
expression. Only severe impairment in the functioning of the
immune system will allow active replication of the virus and
development of PML and the disease is diagnosed mostly in
AIDS patients (Berger and Houff, 2006). The prominent
histopathological findings in PML are multiple foci of myelin
loss in the CNS, oligodendrocytes with enlarged eosinophilic
nuclei containing viral inclusion bodies, and enlarged bizarre⁎ Corresponding author. Fax: +1 215 204 0679.
E-mail address: kamel.khalili@temple.edu (K. Khalili).
0042-6822/$ - see front matter © 2007 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2007.02.015astrocytes with lobulated hyperchromatic nuclei (reviewed in
Del Valle and Piña-Oviedo, 2006; Khalili et al., 2006).
JCV is a member of the polyomavirus family of small DNA
viruses with circular genomes that transform cells in culture and
induce tumors in experimental animals. One feature of
polyomaviruses is their ability to induce genomic instability.
JCV is mutagenic for established cultured cell lines and human
peripheral blood lymphocytes (Theile and Grabowski, 1990).
Antibody titers to JCV have been correlated to chromosomal
aberrations occurring in lymphocytes (Lazutka et al., 1996;
Neel et al., 1996) and JCV infection of human colonic cells
induces chromosomal instability and changes in ploidy
(Ricciardiello et al., 2003). In the case of PML, stoichiometric
analysis of cellular DNA content using the Feulgen technique
indicated the occurrence of hyperploidy in inclusion-bearing
oligodendrocytes and bizarre astrocytes (Ariza et al., 1996).
There is evidence that the closely related polyomaviruses BKV
and SV40 also induce genomic instability (reviewed by White
et al., 2005). Previously, we have examined the effects of
ectopic expression of two JCV regulatory proteins on cellular
processes including DNA repair. These studies examined the
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protein encoded in the late region. Large T-antigen, when
expressed alone in cells, was found to inhibit the high fidelity
pathway of double-strand break (DSB) repair, homologous
recombination directed DNA repair (HRR), and caused the
accumulation of mutations in the affected cells (Trojanek et al.,
2006). Cells expressing T-antigen were found to be much more
sensitive in their ability to recover from γ-irradiation or
cisplatin treatment than T-antigen-negative controls and were
impaired in an assay in which HRR mediated DNA repair leads
to the reconstruction of wild type green fluorescent protein
(GFP) from two non-functional heteroallelic fragments of GFP
cDNA delivered into cells by transfection (Trojanek et al.,
2006). The mechanism for this impairment was found to
involve the cellular DNA repair protein, Rad51.
Ectopic expression of agnoprotein alone in cells was also
found to affect the response of cells to DNA damage. Cells
expressing agnoprotein were more sensitive to the cytotoxic
effects of cisplatin and exhibited increased chromosome
fragmentation, micronuclei formation, and an accumulation of
aneuploid cells (Darbinyan et al., 2004). However, in the case of
agnoprotein, the mechanism of action was found to be due to an
inhibition of the low fidelity pathway of DSB repair, non-
homologous end-joining (NHEJ) through a mechanism involving
the cellular DNA repair protein, Ku70 (Darbinyan et al., 2004).
The studies discussed above involved the introduction of a
single viral protein, large T-antigen, or agnoprotein, into cells by
transfection. In the present studies, we have examined theFig. 1. Genetic instability in astrocytes infected with the Mad-1 strain of JCV. (A)
controls at 5 days and 14 days post-infection. Representative photomicrographs are sh
or aneuploid/hyperploid (≧4n), and the percentage of aneuploid/hyperploid cells plo
Materials and methods and the results plotted for two concentrations of cytochalasinoccurrence of DNA damage, chromosome instability, and
changes in DNA repair during the course of JCV infection of
astrocytes where both early and late proteins are present. We
also have performed immunohistochemistry of clinical samples
of PML and control brains to compare changes in our infected
cell cultures to those that occur in infected astrocytes and
oligodendrocytes in vivo.
Results
To examine molecular and cellular events that occur during
JCV infection, we have developed a cell culture system where
JCV replicates efficiently (Radhakrishnan et al., 2003, 2004).
This consists of purified primary human astrocytes and the
Mad-1 strain of JCV, which was derived from a patient with
PML. In some experiments, we have used the Mad-1/SVEdelta
(Vacante et al., 1989), which is a chimeric virus containing the
Mad-1 genome and part of the SV40 origin. This virus allows
more efficient and timely performance of experiments since
Mad-1/SVEdelta shows enhanced replication in culture (Liu
et al., 1998).
In the first series of experiments to investigate the effect of
JCV infection on cellular DNA, we analyzed colcemid-induced
metaphase spreads from Mad-1 JCV-infected astrocytes and
uninfected controls. As expected, nearly all of the uninfected
cells contained a diploid (2n) content of chromosomes as shown
in Fig. 1A (see panels 1 and 6). However, the JCV-infected
cultures contained a significant number of cells that wereMetaphase spreads were prepared from JCV-infected astrocytes and uninfected
own. (B) For each condition, 70 metaphases were scored as being either diploid
tted for each time point. (C) Micronuclei formation was scored as described in
B.
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shown in Fig. 1A, panel 4, while others contained more than a
tetraploid (>4n) content of chromosomes, e.g., Fig. 1A, panel 3.
In each of cultures, 70 metaphase spreads were scored as either
being diploid or aneuploid/hyperploid and these data are shown
in Fig. 1B. In the uninfected cultures, ≧95% of the cells
contained 2n chromosomes while in the JCV-infected cultures,
∼20% of the cells were aneuploid/hyperploid in the early stage
of infection increasing to 38% in the late stage of infection. To
further analyze changes in cellular DNA upon Mad-1 JCV
infection, micronuclei (MIN) formation assays were performed.
This assay allows the detection of micronuclei that arise from
chromosomal fragments that are not incorporated into daughter
nuclei at mitosis and thus reflect genomic disruption (Heddle,
1973; Kalweit et al., 1999; Kersten et al., 2002). The proportion
of binucleated cells with micronuclei was determined at two
different concentrations of cytochalasin B (0.8 and 1.0 μg/ml)
on day 14 post-infection. As shown in Fig. 1C, MIN formation
was ≤2% in uninfected cultures. However, in the case of the
JCV-infected astrocytes, MIN formation was ∼17% at both
concentrations of cytochalasin B. This indicates that JCV is
inducing genomic disruption in these astrocytes.
When mammalian cells incur double-strand break (DSB)
DNA damage, the histone variant H2AX becomes phosphory-
lated on serine 139 (Rogakou et al., 1998). This phosphorylated
histone, designated γH2AX, is found to cover megabase
chromatin domains surrounding DSBs (Rogakou et al., 1999),
increases in amount linearly with the extent of DSBs (Rogakou
et al., 1999) and is thought to function in the recruitment of
repair factors to nuclear foci after DNA damage (Paull et al.,
2000). To examine H2AX phosphorylation during JCV
infection, primary astrocytes were infected with Mad-1/
SVEdelta JCV and monitored the course of viral infection
during this experiment by Western blot for T-antigen, which is
an early product, VP1 and agnoprotein, which are late products
(Fig. 2A). Tubulin was used as a loading control. We
permeabilized these Mad-1/SVEdelta JCV-infected cells and
uninfected controls (days 4, 8, and 12) and stained with FITC-
conjugated antibody to γH2AX and also with propidium iodide
so that the cell cycle could be examined. γH2AX was increased
after JCV infection, peaking at 8 days (Fig. 2B). Of note for the
cell cycle, the number of cells in the G2/M phases of the cell
cycle was increased at the 12-day time point for the infected
cells compared to the uninfected controls. Also in the infected
cells at day 12, there was an increase in the number of cells
undergoing apoptosis (but not in the control cultures).
The induction of H2AX phosphorylation was also investi-
gated by immunofluorescence. Cell cultures from the 4 day and
8 day time points were replated on glass coverslips and analyzed
by immunocytochemistry using an antibody specific for
phospho-H2AX (anti-γH2AX) at days 5 and 9 after infection,
respectively. As shown in Fig. 2C, immunocytochemistry
confirmed the FACS data that H2AX phosphorylation occurs
upon Mad-1/SVEdelta JCV infection. Phosphorylation of
H2AX was also demonstrated by cell fractionation/western
blotting where cells were lysed in Triton X-100 to extract soluble
proteins followed by DNaseI/high salt extraction to isolate achromatin-associated fraction. In this experiment, γH2AX
appeared in the chromatin-associated fraction of astrocytes
during Mad-1/SVEdelta JCV infection (Fig. 3). H1 and Grb2
were used as markers for the chromatin-associated and soluble
fractions, respectively. Interestingly, H1 was increased in the
chromatin-associated fraction of JCV-infected cells. H1 has
been found to modulate the DNA ligase IV-dependent ligation
of DSBs and is phosphorylated by DNA-dependent protein
kinase (Kysela et al., 2005). Infection of cells was verified by
Western blot with antibody against the JCV capsid protein
VP1.
Next, we analyzed the level of expression of DNA repair
proteins in the cytoplasmic and nuclear fractions of Mad-1/
SVEdelta JCV-infected astrocytes isolated by a two step lysis
procedure designed to separate these two subcellular compart-
ments (Fig. 4A). The most dramatic difference was observed for
the HR DNA repair protein Rad51. Rad51 was barely detectable
in the cytoplasm (lane 7) and nuclei (lane 8) of uninfected
astrocytes but was massively induced at all time points
following JCV infection and was found at high levels in both
the nuclei and cytoplasm. Densitometric analysis allowed a
quantitation of the differences in Rad51 levels in Fig. 4A and
revealed that the induction of Rad51 at days 10 and 15 was 30 to
40-fold when normalized to the expression of Rad51 in the
nuclei of uninfected cells (Fig. 4B). α-Tubulin and lamin A/C
were used as markers for the integrity of the cytoplasmic and
nuclear fractions respectively. Interestingly a band correspond-
ing to cleaved lamin (28 kDa), which is associated with nuclear
membrane disintegration, appeared at the 15-day time point of
Mad-1/SVEdelta JCV infection (Fig. 4A, lane 5, labeled with an
asterisk). This is consistent with the data from Fig. 2A
indicating an increase in apoptosis late in JCV infection. T-
antigen was used to monitor the course of infection. No
dramatic changes were observed for Ku70, Ku80, and NF2. As
expected JCV infection induced the level of p53, which was
localized in the nucleus and peaked at 10 days post-infection.
Interestingly, Nibrin was also induced in nuclei of infected cells.
Next, we investigated the expression of DNA repair protein
but this time using an extraction/separation protocol that allows
the isolation of soluble cellular proteins, which are released by
mild detergent, from chromatin-associated proteins, which are
extracted by high salt and DNase treatment (Fig. 5). Again, we
observed a large induction of Rad51 in Mad-1/SVEdelta JCV-
infected cells that was observed at all time points following JCV
infection. Interestingly there was a moderate increase in the
amount of Ku70 in the chromatin-associated fraction at day 11
following JCV infection (compare lane 3 and 4). Changes were
also observed for the DSB repair protein Artemis (Moshous et
al., 2001). A novel higher molecular weight band appeared in
the chromatin-associated fraction at 11 and 14 days following
JCV infection (lanes 4 and 6, labeled with an asterisk). The
nature of this band, which runs with an apparent molecular
weight of about 100 kDa compared to 97 kDa for full-length
Artemis, is not known but other reports indicate that Artemis
can become heavily phosphorylated in response to DNA
damage and that phosphorylated Artemis migrates more slowly
(Soubeyrand et al., 2006; Zhang et al., 2004).
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cellular distribution of Rad51 was confirmed by immuno-
cytochemistry (Fig. 6). JCV-infected astrocytes expressed
agnoprotein predominantly in the perinuclear region and T-
antigen and VP1 were mainly located in the nucleus. Rad51 was
much higher than in uninfected controls and was found in both
the nuclear and the cytoplasmic compartments of these cells
(Fig. 6, center panels).
Rad51 is a component of the HR DNA repair machinery. To
measure HR DNA requires the introduction of a stably
transfected reporter cassette which is not possible in primary
astrocytes because of their proliferative capacity. For this
reason, we decided to prepare nuclear extracts to repair DNA
substrates in vitro and then sequence the repaired products, i.e.,
this is essentially a NHEJ assay followed by product isolation
and sequencing. We utilized nuclear extracts isolated fromMad-
1/SVEdelta JCV-infected astrocytes and uninfected controls to
assay NHEJ activity. As shown in Fig. 7, uninfected astrocytes
exhibited a measurable rate of NHEJ activity which was
increased at 5 days post-infection but then declined at 11 and 14
days post-infection. To address the question of the fidelity of
these DNA repair processes, we isolated the multimeric
products of NHEJ that were executed by JCV-infected astrocyte
nuclear extracts and those derived from uninfected controls.
After PCR amplification using T7 and T3 primers, the end-
joined products were cloned and 10 clones for each set were
sequenced. As shown in Table 1, two kinds of end-joined
product were found. Both of these products contained the DNA
sequence shown in Table 1, panel A joined at its right hand side
(marked with an asterisk) to the DNA sequence shown in Table
1, panel B joined at its left-hand side (marked with an asterisk).
This corresponds to the joining of the 5′ four nucleotide
overhang from digestion at the BamHI site of pBlueScript(KS+)
substrate (shown in panel A) to the EcoRV blunt end at the other
end of the pBlueScript(KS+) substrate (shown in panel B). In
the first type of product, all genetic information is intact, i.e., the
BamHI 5′ four nucleotide overhang (panel A) is completely
filled in and blunt end ligated to the EcoRV blunt end (panel B).
In the second type of product, genetic information is lost and
three nucleotides of the BamHI site 5′ four nucleotide overhang
are missing from the product (nucleotides shown in white on
black font in panel A). Presumably this triplet is removed by
single-strand exonuclease digestion of the last three nucleotides
of the 5′ overhang and addition of one nucleotide prior to
ligation to the EcoRV blunt end, although since the trinucleotide
“ATC” is repeated at the site of joining, the possibility of the
occurrence of removal of three nucleotides by double-strand
exonuclease digestion of the EcoRVend prior to ligation cannot
be excluded. The two products were designated “triplet intact”Fig. 2. Flow cytometric analysis of cell cycle and γH2AX expression. (A) Cells were
at 4, 8, and 12 days post-infection and stained with FITC-conjugated antibody to ph
cytometry analysis as described in Materials and methods. The peaks corresponding
subdiploid peak defined as the apoptotic peak (APO) and FITC fluorescence used to
cultures shown in panel A to verify the expression of viral proteins during the course
from the 4 day and 8 day time points were replated on glass coverslips and analyzed
γH2AX) at days 5 and 9 after infection, respectively.and “triplet deleted” and their sequence is shown in Table 1,
panel C. All of the products repaired by the nuclear extracts
from JCV-infected astrocytes were “triplet deleted” whereas
most products for the uninfected cells were “triplet intact”
(Table 1, panel C) indicating an important change in DNA
repair caused by JCV infection. It is important to note that HRR
cannot occur in these assays since no recombinational template
for the plasmid substrate is present.
Next, we investigated if the changes that were observed in
JCV infection of primary astrocytes in culture were reflected in
PML patients infected with JCV in vivo. Brain samples were
obtained from three HIV-positive PML patients and controls
from three HIV-positive patients without PML and three HIV-
negative patients without PML. A series of immunohistochem-
ical studies were performed on these archival PML samples.
Expression of Rad51 was absent in normal astrocytes (identified
by labeling with GFAP) in a representative non-PML control
brain sample (Fig. 8, panels A–C). In contrast a GFAP positive
bizarre astrocyte within a demyelination plaque in a case of
PML (panel D, Rhodamine), shows robust and abundant
nuclear foci of Rad51 (panels E, fluorescein and F, double-
labeling). On the other hand, enlarged oligodendrocytes
harboring intra-nuclear inclusion bodies, labeled with VP1
(panel G, rhodamine), show a discrete number of Rad51 foci
(panels H, fluorescein and G, double-labeling). An elevation of
Rad51 in HIV+ PML+ samples relative to HIV+ PML− and
HIV−PML− samples was confirmed by Western blot analysis
of proteins extracted from homogenates of the frozen brain
patient samples (data not shown). Detection of Ku70 was found
in the cytoplasm of bizarre astrocytes of PML brain (Fig. 9,
panel A), and JCV-infected oligodendrocytes (panel B).
Although bizarre astrocytes are characteristic, their glial nature
was corroborated by double-labeling with GFAP and Ku70
(panel C). On the other hand, Ku80 was detected in the nuclei of
both phenotypes, bizarre astrocytes (panel D), and oligoden-
drocytes harboring inclusion bodies (panel E), as corroborated
with double labeling for GFAP and Ku80 (panel F). Expression
of Ku70 and Ku80 was undetectable in regions of the same
brain samples outside of the PML plaque lesion and in
immunohistochemistry of non-PML brain controls (data not
shown). Finally, other DNA repair proteins were detected in the
glial cells affected by JCV in cases of PML. Artemis was found
in the cytoplasm of bizarre astrocytes (Fig. 10, panel A), Mre11
was present also in the cytoplasm of bizarre astrocytes (panel
B), Nibrin was detected in the cytoplasm of both phenotypes,
bizarre astrocytes and enlarged oligodendrocytes (panel C), and
Chk1 was found expressed in the cytoplasm of bizarre
astrocytes and in the nuclei of oligodendrocytes harboring
inclusion bodies (panel D). Expression of Mre11, Nibrin andharvested fromMad-1/SVEdelta JCV-infected astrocytes and uninfected controls
ospho-Histone H2AX (Ser139) and with propidium iodide and subject to flow
to each of the different stages of the cell cycle are plotted against time with the
define the phosphorylation of histone H2AX (γH2A). (B) Western blot of the
of infection. These experiments were conducted three times. (C) Cells cultures
by immunocytochemistry using an antibody specific for phospho-H2AX (anti-
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Fig. 3. Western blot analysis of γH2AX expression. Mad-1/SVEdelta JCV-
infected astrocytes and uninfected controls were harvested at 6, 11, and 14 days
post-infection and fractionated into chromatin-associated and soluble compo-
nents as described in Materials and methods. γH2AX was measured by Western
blot. H1 and Grb2 were used as fractionation and loading controls. Infection was
verified by Western blot to VP1.
Fig. 4. Expression of DNA repair proteins in the cytoplasmic and nuclear
subcellular compartments. (A) Astrocytes infected with Mad-1/SVEdelta JCV
for 5, 10, and 15 days and uninfected controls were subject to subcellular
fractionation and cytoplasmic (C) and nuclear (N) proteins were harvested.
These were subject to Western blot analysis for DNA repair proteins. To assess
the purity of the fractions, α-tubulin was used as a marker for cytoplasm and
lamin A/C as a marker for the nucleus. The asterisk indicates a band
corresponding to the cleaved form of lamin (28 kDa). T-antigen was used as a
marker for infection. Ku70 runs as multiple bands, which may be due to
phosphorylation. (B) Quantitation of the differences in Rad51 levels in panel A
was performed by densitometric analysis of the X-ray film scanned on a
Molecular Imager FX with the Quantity One Program (Bio-Rad, Hercules CA).
The results were normalized relative to expression of Rad51 in the nuclei of
uninfected cells and are presented as a histogram.
78 A. Darbinyan et al. / Virology 364 (2007) 73–86Chk1 was undetectable in regions of the same brain samples
outside of the PML plaque lesion and in immunohistochemistry
of non-PML brain controls (data not shown).
Discussion
We have found that JCV infection of primary human fetal
astrocytes induces chromosomal instability and DNA damage
as evidenced by the occurrence of aneuploidy/hyperploidy in
metaphase spreads which increases with time of infection,
induction of micronuclei which are an indicator of chromoso-
mal fragmentation (Heddle, 1973; Kalweit et al., 1999; Kersten
et al., 2002), and the phosphorylation of the histone H2AX on
serine 139 (γH2AX) which is a marker of double strand DNA
breaks (Paull et al., 2000; Rogakou et al., 1998, 1999). γH2AX
induction by JCV infection was detectable by FACS analysis,
immunocytochemistry, and Western blot. As described in the
Introduction, it has previously been reported that JCV
transformation of non-permissive cells, such as white blood
cells and colon cells, is associated with the induction of
genomic instability (Lazutka et al., 1996; Neel et al., 1996;
Ricciardiello et al., 2003; Theile and Grabowski, 1990). Now
we have documented the occurrence of these changes during the
course of productive infection of permissive primary cells that
support the active replication of JCV, a virus of narrow tropism.
In previous reports, we have examined the effects of JCV
large T-antigen and agnoprotein on cellular DNA repair. Both
viral proteins impaired the ability of cells to respond to DNA
damage: large T-antigen was found to inhibit HR DNA repair
while agnoprotein was found to inhibit NHEJ. However, there
are two important differences between the experimental contexts
of these studies and the present studies. Firstly, the previous
studies utilized cell lines that expressed the particular viral
protein by itself. In this study, viral infection is used and all viral
proteins are expressed and in differing amounts in the early and
late stages of infection. Secondly, the previous studies utilizedestablished cell lines that constitutively express the viral protein.
In the case of T-antigen, JCV T-antigen positive and negative
mouse medulloblastoma cell lines were compared (Trojanek
Fig. 5. Expression of DNA repair proteins in chromosome-associated and
soluble fractions. Astrocytes infected with Mad-1/SVEdelta JCV for 6, 11, and
14 days and uninfected controls were subject to a fractionation procedure to
separate soluble proteins (released by mild detergent) from proteins associated
with chromatin (released by high salt and DNase treatment). These are labeled as
“Sol” and “Chr,” respectively. These were subject to Western blot analysis for
DNA repair proteins. The asterisk denotes a band in the Artemis Western blot
which runs at about 100 kDa compared to 97 kDa for full-length Artemis. Ku70
runs as multiple bands, which may be due to phosphorylation.
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negative mouse 3t3 fibroblasts were used (Darbinyan et al.,
2004). In both cases, selection has been made in the cell cultures
for cells that are able to survive and grow progressively. In this
situation, chronic changes in cellular physiology might be
expected to occur that permit the cell to tolerate the viral protein.
While this is very important in understanding the mechanisms of
JCV-mediated tumorigenesis, there may be important differ-
ences to the context of viral infection. In this study we are
interested in understanding the acute events occurring during
viral replication where the end point is cell death and virus
release. In other words, the differences observed in the
perturbations in DNA repair between the experiments reported
here and our earlier reports may be due to one or more important
differences in the experimental settings including cell type
(human astrocytes versus rodent fibroblast) and the nature of
expression (acute expression of multiple viral proteins versus
chronic expression of a single viral protein).
The chromosome abnormalities resulting from JCV infection
occur early in infection with 20% cells being hyperploid/
aneuploid after 5 days suggesting that a viral early protein is
involved. In the case of the closely related polyomavirus SV40,
it has long been known to induce chromosomal abnormalities
(Marshak et al., 1975) and this function is associated with largeT-antigen (Ray et al., 1990, 1992; Stewart and Bacchetti, 1991).
Attempts to map the function to subdomains within the SV40 T-
antigen protein using mutants have yielded conflicting results
implicating the N-terminal pRb-binding domain (Woods et al.,
1994) or the p53-binding domain (Ray et al., 1998). JCV T-
antigen is also able to bind to pRb and p53 (Krynska et al.,
1997; White et al., 2006). Yet other reports have implicated the
interaction of SV40 T-antigen with other proteins for the
induction of genetic instability. These include Nbs1 in the
disruption of DNA replication control (Wu et al., 2004), Mre11
in nuclear DNA-repair foci (Digweed et al., 2002), and Bub1,
the spindle assembly checkpoint protein that is part of the
machinery that ensures the correct segregation of chromosomes
at mitosis (Cotsiki et al., 2004).
Infection of astrocytes with JCV also affects their cell cycle
profiles (Fig. 2). The percentage of cells in G2/M is increased
especially late in infection. This could be due to induction of
the G2/M checkpoint in these cells. This checkpoint serves to
delay the entry of cells into mitosis in response to DNA
damage so as to allow time for DNA repair. Thus the DNA
damage induced by JCV may be responsible for the increase in
the number of cells in the G2/M phase. The cell cycle profiles
also reveal that the number of cells undergoing apoptosis is
increased late in infection. Interestingly, this is correlated with
the appearance of cleaved lamin, a marker for apoptosis (Fig.
4). Remarkably, cultures in the late stage of infection exhibit a
profound cytopathic effect and have severe DNA damage but
less than 6% of them are apoptotic (Fig. 2). In this regard, we
have recently found that JCV infection induces expression of
the inhibitor of apoptosis protein, Survivin (Pina-Oviedo et al.,
in press).
Western blot analysis of various subcellular fractions from
JCV-infected and uninfected astrocytes shows the perturbation
in the levels of expression of some important DNA repair
proteins. The most notable of these is a very large induction in
the expression of the HR-DNA repair protein, Rad51. Induction
was seen in nuclear and cytoplasmic fractions (Fig. 4), in
chromatin-associated and soluble fractions (Fig. 5) and by
immunocytochemistry (Fig. 6). In clinical brain samples from
PML patients relative to non-PML brain controls, Rad51
induction was detected by Western blot (Fig. 8) and
immunohistochemistry where Rad51 was detected in the bizarre
giant astrocytes that are characteristic of PML (Fig. 9). Also of
interest, a higher molecular weight protein band was observed
in Western blots of Artemis in JCV-infected astrocyte cultures
but not controls. This runs at about 100 kDa compared to
97 kDa for full-length Artemis and may be due to phosphoryla-
tion of Artemis in response to DNA damage (Soubeyrand et al.,
2006; Zhang et al., 2004).
The relationship of the occurrence of DNA damage to changes
in DNA repair proteins during JCV infection poses a chicken and
egg question. On the one hand, it is possible that DNA damage is
caused by JCV infection and then the cell responds by inducing
DNA repair proteins. On the other hand, it is possible that JCV
infection induces DNA repair proteins inappropriately and that
this subsequently leads to defective DNA repair and DNA
damage. In this regard, we recently reported that transient
Fig. 6. Immunocytochemical detection of Rad51 expression. Primary human astrocytes were prepared, plated on glass cover slips, and infected with Mad-1/SVEdelta
JCVor used as uninfected controls. Immunocytochemistry was performed with labeling for viral proteins as indicated (left hand panels, red), Rad51 (center panels,
green), and double labeling (right hand panels).
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antigen strongly stimulates transcription from the Rad51
promoter (White et al., 2006). This induction was observed in
the p53-null Saos2 cell line and hence is independent of p53,
which is a repressor of the Rad51 promoter (Arias-Lopez et al.,
2006). However T-antigen stimulation of the Rad51 promoter
was not abrogated by cotransfection of a plasmid expressing p53
(White et al., 2006). Rad51 overexpression has been shown to
promote alternative double-strand break repair pathways leadingto genomic instability, chromosomal breaks, and aneuploidy
(Richardson et al., 2004). Paradoxically when Rad51 is over-
expressed it reduces DSB-induced HR DNA repair perhaps
because excess Rad51 blocks DNA strand exchange (Kim et al.,
2001). Indeed, despite its role in maintaining genomic integrity,
the aberrant increase in Rad51 expression that is found in tumor
cells may contribute to genomic instability by promoting
abnormal recombination between short repetitive elements and
homologous sequences (Raderschall et al., 2002; Richardson
Fig. 7. Non-homologous end-joining DNA repair assay. Nuclear extracts were
prepared from uninfected astrocytes and from astrocytes infected with Mad-1/
SVEdelta JCV for 5, 11, and 14 days. NHEJ assays were performed with a
linearized plasmid substrate as described in Materials and methods and the
reactions run on an ethidium bromide/agarose gel. The position of the products
is indicated by the bracket. The substrate is indicated with an arrow. The lane
labeled “*” indicates the negative control (no nuclear extract).
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promoter is induced by T-antigen early in the infection of
astrocytes by JCV and that excess Rad51 promotes subsequent
genetic instability. Products from DNA substrates joined in vitro
by extracts from the nuclei of JCV-infected astrocytes differTable 1significantly from those from uninfected cells (Table 1) although
it is uncertain if excess Rad51 is involved in this phenomenon.
The alteration in DNA repair pathways that we have reported
may be important for the life cycle of JCVand the pathogenesis
of PML. Rad51 may have a direct role in viral replication or
may indirectly promote the virus life cycle indirectly through
effects on other cellular factors. Additionally when cells are
non-permissive or semi-permissive for JCV replication, cells
that are not killed by the virus may become transformed by T-
antigen. T-antigen-induced Rad51 expression in these cells may
cause genomic instability that may contribute to the early stages
of progression of JCV-associated tumors.
Materials and methods
Antibodies and Western blotting
The following antibodies were used for Western blotting:
Ku70 – AHP316 (Serotec, Raleigh, NC), Ku80 – AHP317
(Serotec), Grb2 – 610111 (BD Biosciences, San Jose, CA),
Rad51 – clone 3C10 (Upstate Biotechnology, Lake Placid, NY),
p53 – Ab1 (Oncogene Science, clone 421), JCV T-antigen –
PAb2 (Oncogene Research Products, clone PAb 416), α-tubulin
(T6074; Sigma, St. Louis, MO), Histone H1 –AE-4 (Santa Cruz
Biotechnology, Inc., Santa Cruz, CA), anti-phospho-H2A.X
Fig. 8. Detection of the DNA repair protein Rad51 in glial cells of PML. Samples were obtained from HIV-negative patients without PML (HIV−, PML−), HIV-
positive patients without PML (HIV+, PML−), and HIV-positive patients with PML (HIV+, PML+) and analyzed by immunohistochemistry as described in Materials
and methods. Normal astrocytes in the cortex of a control brain were labeled with Glial Fibrillary Acidic Protein (panel A, rhodamine), and showed no expression of
Rad51 (panels B, fluorescein and C, double labeling). Bizarre astrocytes within demyelination plaques in cases of progressive multifocal leukoencephalopathy, also
labeled for GFAP (panel D, rhodamine), demonstrated numerous foci of Rad51 in the nuclei (panels E, fluorescein and F, double labeling). JCV-infected
oligodendrocytes were labeled with VP1 (panel G, rhodamine), highlighting the intranuclear viral inclusion body, and showed minimal foci of Rad51 in the same
nuclear location (indicated by arrows in panels H, fluorescein, and I, double labeling). All panels original magnification ×1000.
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(Abcam, Cambridge, MA), Nibrin – (Santa Cruz), Lamin A/C,
Chk1, phospho-Chk2 (Thr68) – (Cell Signaling, Danvers MA),
NF2 – sc-332 (Santa Cruz). We have previously described rabbit
polyclonal antibody against JCV agnoprotein and VP1 (Del
Valle et al., 2002). Western blotting was performed as described
earlier (Darbinyan et al., 2004).
JCV infection of astrocytes
Primary cultures of human astrocytes were prepared and
infected with either JCV strain Mad-1 or with the chimeric
Mad-1/SVEdelta virus as described previously (Radhakrish-
nan et al., 2003, 2004) at an moi=1. Cells were freshly
prepared and purified for each experiment. At 5–6, 10–11
and 14–15 days after infection, cells were harvested and
analyzed as described below together with uninfected controlcultures. Note that in infected cultures, virus production
precedes cytopathic effect: we have found virus in the
supernatant of infected cultures at a level of 106 and 107 viral
copies/ml at day 5 and day 15 post-infection, respectively
(Radhakrishnan et al., 2004). The mechanism of viral release
is thought to be via endosome formation similar to SV40
(Clayson et al., 1989).
Metaphase spreads
Metaphase spreads were prepared as we have previously
described (Darbinyan et al., 2004). Briefly, cells were treated for
2 h with 100 ng/ml colcemid. After mitotic arrest, cells were
harvested, treated with 0.075 M KCl, and fixed with methanol:
acetic acid (3:1). The cell suspension was dried on a glass slide,
stained in 0.4% Giemsa, soaked in xylene, and mounted in
SP15-100 Permount (Fisher, Pittsburgh, PA). Photomicrographs
Fig. 9. Detection and cellular localization of DNA repair enzymes Ku70 and Ku80 in cases of PML. Immunohistochemistry against the DNA repair enzyme Ku70
demonstrated its presence in the cytoplasm of bizarre atypical astrocytes of PML (panel A), and weakly in the cytoplasm of JCV-infected oligodendrocytes harboring
intranuclear inclusion bodies (panel B). Double labeling with GFAP (fluorescein) demonstrates the astrocytic nature of the cells expressing Ku70 (panel C,
rhodamine). Immunohistochemistry for Ku80 showed that it was robustly expressed in the nuclei of bizarre astrocytes (indicated by an arrow in panel D) and in the
nuclei and cytoplasm of enlarged oligodendrocytes (panel E). Double labeling (panel F) with GFAP (fluorescein) shows the location of Ku80 (rhodamine) in astrocytes
(arrow) and the presence in the nucleus of a non-labeled JCV-infected oligodendrocyte (arrowhead). Panels A and D, original magnification ×400; all other panels,
original magnification ×1000. Labeling for Ku70 or Ku80 was not observed in areas outside of the PML lesions or in brain samples from the control patients without
PML (data not shown).
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magnification of 700×.
Micronuclei formation assay
Micronuclei formation was assayed as we have previously
described (Darbinyan et al., 2004). Cells were treated for 24 h
with cytochalasin B (0.8 and 1.0 μg/ml) to block cytoplasmic
but not nuclear division, washed, fixed in methanol, allowed to
air dry, and stained with 0.4% Giemsa. The proportion of
binucleated cells with micronuclei was determined.
Flow cytometric analysis
Cells were harvested, washed with PBS, and fixed in
suspension in 1%methanol-free formaldehyde in PBS on ice for
20 min. Cells were then resuspended in 73% ethanol for at least
16–20 h at −20 °C. Cells were washed with PBS and gently
resuspended in 0.2% Triton X-100 in PBS/1%BSA for 30 min.
Following low speed centrifugation, cells were incubated with
anti-phospho-Histone H2A.X (Ser139)-FITC-conjugated anti-
body (mouse monoclonal, Upstate Biotechnologies, #16-202A)
in 1% BSA in PBS overnight at 4 °C. This antibody is also
known as anti-γH2AX and only recognizes H2AX that is
phosphorylated on the serine at position 139. Cells were thenwashed with PBS and stained with propidium iodide in PBS/
RNase A. Flow cytometry was performed with a COULTER®
EPICS® FACScan flow cytometer to determine the cell cycle
distribution and measure the green fluorescence.
Immunocytochemistry for γH2AX
Primary human fetal astrocytes were prepared and seeded
on polylysine-coated glass chamber slides and left uninfected
or infected with JCV (Mad-1/SVEdelta). At 5 days or 9 days
after infection, cells were fixed with 4% paraformaldehyde.
Fixed cells were blocked with 5% BSA in PBS for 2 h and
incubated with anti-phospho-Histone H2A.X (Ser139)-FITC-
conjugated antibody (mouse monoclonal, Upstate Biotechnol-
ogies, #16-202A) for 16 h. Cells were then washed three times
with PBS-0.01% Tween-20 at 10 min intervals. Slides were
washed three times with PBS, mounted, and examined by
fluorescence microscopy.
Preparation of nuclear and cytoplasmic fractions
Cell cultures were extracted to give nuclear and cytoplasmic
fractions using the NE-PER nuclear and cytoplasmic reagents
(Pierce Biotechnology, Rockford, IL) as we have previously
described (White et al., 2006).
Fig. 10. Immunohistochemical detection of other DNA repair proteins in cases of PML. Bizarre astrocytes within demyelinated plaques of PML show cytoplasmic
immunoreactivity for Artemis (panel A). MRE11 was weakly detected in the cytoplasm of bizarre astrocytes from PML (panel B). Immunohistochemistry for Nibrin
(panel C) showed that it was found in the cytoplasm of both bizarre astrocytes (arrowhead) and enlarged oligodendrocytes harboring inclusion bodies (arrow).
Immunohistochemistry for Chk1 (panel D) shows cytoplasmic reactivity in bizarre astrocytes (arrowhead) and in the nuclei of oligodendrocytes (arrows). All panels
original magnification ×400 except panel B ×200. Immunolabeling for MRE11, Nibrin, or Chk1 was not observed in areas outside of the PML lesions or in brain
samples from the control patients without PML (data not shown).
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Chromatin-associated and soluble fractions were prepared
based on the method of Mirzoeva and Petrini (2003). Briefly,
astrocytes were harvested by trypsinization, resuspended in
growth media, and counted. Cells were lysed in ice-cold CSK
buffer [10mMPIPES (pH 6.8), 100mMNaCl, 300mM sucrose,
3 mM MgCl2, 1 mM EGTA, 0.5% Triton X-100 supplemented
with 1 mM phenylmethylsulfonyl fluoride, 5 μg/ml leupeptin,
2 μg/ml aprotinin, 1 mMATP, 10 mM sodium-orthovanadate for
10 min at 2.5×107 cells/ml. The supernatant from low-speed
centrifugation (5 min, 1500×g, 4 °C) constituted the soluble
fraction that was subsequently clarified by high-speed centrifu-
gation (15 min at 14,000×g, 4 °C). The low-speed pellet (intact
nuclei, verifiedmicroscopically), was washed once with ice-cold
CSK buffer (5 min, 1500×g, 4 °C) and incubated in CSK buffer
containing 50 units of RNase-free DNase I (Roche Biochem-
icals, Basel, Switzerland) at 1×108 nuclei/ml for 30 min at
37 °C. DNase-treated nuclei were collected by centrifugation
(15 min, 14,000×g, 4 °C) and the supernatant was retained. The
DNase pellet was washed once in 1 ml of ice-cold CSK buffer
(5 min, 16,000×g, 4 °C) and incubated in ice-cold CSK buffer
containing 500 mM NaCl for 10 min at 4 °C. This extract was
clarified by centrifugation (15 min, 14,000×g, 4 °C) and pooled
with the DNase-treated fraction, constituting the chromatin-
associated, or insoluble, fraction. The protein concentration was
determined by Bradford assay and 25 μg for soluble fraction and
5 μg for insoluble were resolved by 10% SDS-PAGE and
Western blotted as described previously (Darbinyan et al., 2004).Double-labeling immunocytochemistry for Rad51 and JC viral
proteins
Five days post-infection with JCV (Mad-1/SVEdelta),
primary cell cultures and uninfected controls were fixed
with cold acetone for 3 min and rinsed with PBS. Cells were
blocked with normal horse or goat serum for 1 h at room
temperature and incubated with primary antibodies overnight.
Primary antibodies for viral proteins included a mouse
monoclonal anti SV40 T-antigen, which cross-reacts with
JCV T-antigen (Ab2, Clone PAb416, 1:100 dilution, Onco-
gene), a mouse monoclonal anti-VP1 (1:2000 dilution,
generously provided by Dr. Walter Atwood, Brown Uni-
versity, Providence, Rhode Island), and a rabbit polyclonal
anti-agnoprotein (1:1000 dilution) (previously described in
Del Valle et al., 2002). After rinsing thoroughly with PBS, a
rhodamine-tagged secondary anti-mouse or anti-rabbit anti-
body was incubated for 1 h at room temperature in the dark.
Then the cultures were treated with a basic buffer solution
containing 0.02% Triton X-100 and re-blocked with normal
horse serum for 1 h, after which a Rad51 antibody (Ab-2,
Clone 51RAD01, Calbiochem, 1:50 dilution) was incubated
overnight. After rinsing with PBS an anti-mouse fluorescein-
tagged secondary antibody was incubated for 1 h in the dark.
Finally the chambers were detached, the slides were mounted
with an aqueous-based mounting media (Vector Laboratories),
and visualized with a UV fluorescent microscope (Nikon),
and images were processed using deconvolution software
(Slidebook 4.0, Intelligent Imaging, Denver, Colorado).
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DNA repair
NHEJ assays were as we have previously described
(Darbinyan et al., 2004). Nuclear extracts were prepared from
control and Mad-1/SVEdelta JCV-infected astrocytes (5, 11,
and 14 days post-infection) using hypotonic lysis buffer
followed hypertonic nuclear lysis buffer and 3 rapid cycles of
freezing-thawing. The nuclear lysates were cleared by
centrifugation, dialyzed, and NHEJ assays performed using a
DNA substrate consisting of plasmid pBlueScript(KS+)
linearized by restriction endonuclease digestion with BamHI
and EcoRV. This DNA substrate is thus an approximately 3 kb
linear molecule with a 4 nucleotide 5′ overhang at one end
(BamHI) and the other end blunt (EcoRV). The resulting 3 kb
linear DNA substrate fragment was added to end-joining
reactions containing nuclear extracts and were incubated for 1 h
at 37 °C. DNA products were deproteinized by treatment with
proteinase K and analyzed by electrophoresis through a 0.7%
agarose gel.
Sequence analysis of DNA products resulting from NHEJ
reactions
NHEJ reactions were performed as described in the previous
section and the multimeric products purified from the agarose
gel for each of the NHEJ reactions. PCR was performed using
standard T7 and T3 primers which flank the end-joined region
of the DNA. The PCR products were cloned into the pCR2.1
plasmid (Invitrogen) and 10 plasmids containing PCR inserts
were selected for each set and analyzed by sequencing.
Clinical brain samples
A total of 12 archival cases of formalin fixed, paraffin
embedded PML cases with their respective controls were
collected from the NIH National Tissue Consortium at the
Manhattan Brain Bank, Mount Sinai School of Medicine, New
York, New York. Frozen portions of parieto-occipital lobe
from three HIV negative, three HIV positive (no pathology)
and three HIV-related PML cases were also obtained from the
archives of the Manhattan Brain Bank. Patients were 41–52
years old males.
Immunohistochemistry for brain samples
Immunohistochemistry was performed as we have previously
described (Enam et al., 2005) using the avidin–biotin–
peroxidase system according to the manufacturer's instructions
(Vector Laboratories). Our modified protocol includes depar-
affination in xylene, re-hydration in alcohol up to water, non-
enzymatic antigen retrieval in citrate buffer, pH 6.0 at 95 °C for
30 min. After a cooling period, endogenous peroxidase
quenching was performed with 0.3% H2O2 in methanol for
20 min. Sections were rinsed with PBS and blocked with normal
horse or goat serum (for mouse monoclonal or rabbit polyclonal
antibodies respectively), and incubated with primary antibodiesovernight at room temperature in a humidified chamber. Primary
antibodies utilized included rabbit polyclonal antibodies against
Artemis (AbCam, ab18319, 1:250 dilution), Mre11 (Santa Cruz
Biotechnology, H300, 1:500 dilution), Chk1 (Santa Cruz
Biotechnology (FL-476, 1:00 dilution), and a goat polyclonal
anti-Nibrin (Santa Cruz Biotechnology, C-19, 1:200 dilution).
For theMre11 antibody we utilized frozen sections. After rinsing
with PBS a biotinylated secondary antibody was incubated for
1 h, then avidin–biotin–peroxidase complexes (ABCKit, Vector
Laboratories), then sections were developed with diaminoben-
zidine (Sigma), and finally sections were counterstained with
hematoxylin and mounted. For detection of Rad51, we modified
our protocol to include a basic buffer containing Triton X-100 in
each step. We utilized a mouse monoclonal antibody against
human Rad51 (Ab-2, Clone 51RAD01, 1:50 dilution), and we
labeled with a fluorescein-tagged secondary antibody as
described for immunocytochemistry.
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